CF
KRRO icon

Centaurus Financial’s Korro Bio KRRO Stock Holding History

Centaurus Financial’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-348
Closed -$67K – 927
2022
Q4 		$67K Buy
348
+104
+43% +$10.7K 0.01% 817
2022
Q3 		$22K Sell
244
-198
-45% -$20.1K ﹤0.01% 846
2022
Q2 		$33K Buy
442
+240
+119% +$16.2K ﹤0.01% 824
2022
Q1 		$21K Buy
+202
New +$38.6K ﹤0.01% 886
2021
Q4 		– Sell
-201
Closed -$71K – 955
2021
Q3 		$71K Hold
201
– – 0.01% 876
2021
Q2 		$100K Buy
+201
New +$98.1K 0.01% 873
2021
Q1 		– Sell
-91
Closed -$160K – 854
2020
Q4 		$160K Buy
+91
New +$120K 0.02% 607

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.56B AUM 17.72% 1-Year Est. Return

Centaurus Financial's KRRO Position: Q1 2023 in Review

Centaurus Financial sold out of Korro Bio (KRRO) in Q1 2023, closing a stake of 348 shares — an estimated $67K sold.

Centaurus Financial first reported a position in KRRO in Q4 2020 and held it in 7 quarters. The position peaked at $160K in Q4 2020. 43 funds tracked by Wall St. Rank hold KRRO as of Q1 2023.

  • Centaurus Financial reported no remaining Korro Bio position as of Q1 2023 after selling out during the quarter.
  • Centaurus Financial sold 348 Korro Bio shares in Q1 2023, an estimated $67K.
  • Centaurus Financial first reported a position in Korro Bio in Q4 2020 and held it in 7 quarters.
  • Centaurus Financial's Korro Bio position peaked at $160K in Q4 2020.
  • 43 funds tracked by Wall St. Rank held Korro Bio as of Q1 2023.

Based on Centaurus Financial's 13F filing for Q1 2023, filed 18 May 2023.